Sinus Tachycardia: a Multidisciplinary Expert Focused Review.

Stavros Stavrakis, Brian Olshansky, Julian Stewart, David S Goldstein, Fetnat Fouad-Tarazi, Satish R Raj, Erik H Van Iterson, Qi Fu, Nicole E Zahka, Barbara K Bruce, Cem Akin, David C Kem, Mark Belham, James A S Muldowney, Jeffrey J Goldberger, Tamanna Singh, Kenneth A Mayuga, Mohamed H Hamdan, Blair P Grubb, Kalyanam Shivkumar, Hiba AbouAssi, Mirna B Ayache, Robert Sheldon, David Benditt, Mina Chung, Dan Sorajja, Peter Hanna, Christopher Gibbons, Jonathan Walter Dukes, Rakesh Gopinathannair, Fabrizio Ricci, Artur Fedorowski

Journal: Circulation. Arrhythmia and electrophysiology 2022;15(9):e007960

PMID: 36074973

Free Full Text on PubMed Central View on PubMed

Abstract

Sinus tachycardia (ST) is ubiquitous, but its presence outside of normal physiological triggers in otherwise healthy individuals remains a commonly encountered phenomenon in medical practice. In many cases, ST can be readily explained by a current medical condition that precipitates an increase in the sinus rate, but ST at rest without physiological triggers may also represent a spectrum of normal. In other cases, ST may not have an easily explainable cause but may represent serious underlying pathology and can be associated with intolerable symptoms. The classification of ST, consideration of possible etiologies, as well as the decisions of when and how to intervene can be difficult. ST can be classified as secondary to a specific, usually treatable, medical condition (eg, pulmonary embolism, anemia, infection, or hyperthyroidism) or be related to several incompletely defined conditions (eg, inappropriate ST, postural tachycardia syndrome, mast cell disorder, or post-COVID syndrome). While cardiologists and cardiac electrophysiologists often evaluate patients with symptoms associated with persistent or paroxysmal ST, an optimal approach remains uncertain. Due to the many possible conditions associated with ST, and an overlap in medical specialists who see these patients, the inclusion of experts in different fields is essential for a more comprehensive understanding. This article is unique in that it was composed by international experts in Neurology, Psychology, Autonomic Medicine, Allergy and Immunology, Exercise Physiology, Pulmonology and Critical Care Medicine, Endocrinology, Cardiology, and Cardiac Electrophysiology in the hope that it will facilitate a more complete understanding and thereby result in the better care of patients with ST.

Address: Section of Cardiac Electrophysiology and Pacing, Department of Cardiovascular Medicine, Cleveland Clinic, OH (K.A.M.).; Karolinska Institutet & Karolinska University Hospital, Stockholm, Sweden (A.F.).; Department of Neuroscience, Imaging and Clinical Sciences, "G.d'Annunzio" University of Chieti-Pescara, Chieti Scalo, Italy (F.R.).; Kansas City Heart Rhythm Institute, Overland Park (R.G.).; Community Memorial Hospital, Ventura, CA (J.W.D.).; Beth Israel Deaconess Medical Center, Boston, MA (C.G.).; University of California, Los Angeles (P.H.).; Mayo Clinic Arizona (D.S.).; Section of Cardiac Electrophysiology and Pacing, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH (M.C.).; University of Minnesota Medical School, Minneapolis (D.B.).; University of Calgary, Canada (R.S.).; MetroHealth Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH (M.B.A.).; Division of Endocrinology, Metabolism, and Nutrition, Duke University Medical Center, Durham, NC (H.A.A.).; University of California, Los Angeles (K.S.).; The University of Toledo Medical Center, OH (B.P.G.).; University of Wisconsin, Madison (M.H.H.).; University of Oklahoma Health Science Center, Oklahoma City (S.S.).; Department of Cardiovascular Medicine, Cleveland Clinic, OH (T.S.).; Division of Cardiology, Department of Medicine, University of Miami, FL (J.J.G.).; Vanderbilt University Medical Center &Tennessee Valley Healthcare System, Nashville Campus, Department of Veterans Affairs, TN (J.A.S.M.).; Cambridge University Hospitals NHS FT, United Kingdom (M.B.).; University of Oklahoma Health Sciences Center, Oklahoma City (D.C.K.).; University of Michigan, Ann Arbor (C.A.).; Mayo Clinic, Jacksonville, FL (B.K.B.).; Cincinnati Children's Hospital Medical Center, OH (N.E.Z.).; Institute for Exercise and Environmental Medicine at Texas Health Presbyterian Hospital Dallas & University of Texas Southwestern Medical Center (Q.F.).; Section of Preventive Cardiology & Rehabilitation, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Miller Family Heart, Vascular & Thoracic Institute, Cleveland Clinic, OH (E.H.V.I.).; Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Canada (S.R.R.).; Cleveland Clinic, OH (F.F.-T.).; CNP/DIR/NINDS/NIH, Bethesda, MD (D.S.G.).; New York Medical College, Hawthorne (J.S.).; University of Iowa (B.O.).

DOI: 10.1161/CIRCEP.121.007960

Link outs

Free resources

Full Text Sources:

Medical:

https://medlineplus.gov/covid19coronavirusdisease2...

Subscription / membership required

Full Text Sources:

MeSH Terms: COVID-19, Humans, Postural Orthostatic Tachycardia Syndrome, Tachycardia, Sinus